Theravance Biopharma Inc
NASDAQ:TBPH
Theravance Biopharma Inc
Interest Income Expense
Theravance Biopharma Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theravance Biopharma Inc
NASDAQ:TBPH
|
Interest Income Expense
$6.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
See Also
What is Theravance Biopharma Inc's Interest Income Expense?
Interest Income Expense
6.8m
USD
Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Interest Income Expense amounts to 6.8m USD.
What is Theravance Biopharma Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-12%
Over the last year, the Interest Income Expense growth was 208%.